Objective: We examined 11-year trends in resistance and resistant microorganism isolation rates per 1,000 patient-days of key Gram-positive and Gram-negative bacteria in a Turkish tertiary-care hospital.
Materials and Methods: Microbiology data were obtained from the first isolate per patient per admission between January 2014 and December 2024. Organisms were identified by VITEK MS/MALDI-TOF, antimicrobial susceptibility was determined by VITEK2 or BD Phoenix (disk diffusion for selected agents), applying CLSI breakpoints throughout and EUCAST from 2015 onward. Resistance rates (%) and resistant organism isolation rates per 1,000 patient-days were calculated.
Results: Enterococcus faecalis remained highly susceptible throughout the study period. In contrast, Enterococcus faecium showed progressive increases in ampicillin and vancomycin resistance, with ampicillin-resistant bloodstream isolation rates approximately doubling from 0.405 in 2014 to 0.773 in 2023. Methicillin-resistant Staphylococcus aureus isolation rates rose sharply over the same period, from 0.230 in 2014 to 0.945 in 2022 in the non-bloodstream. Carbapenem resistance of Acinetobacter baumannii remained persistently high but broadly stable, except for a notable spike in 2021. Resistance rates and isolation rates per 1,000 patient-days of K. pneumoniae to carbapenems (29% to 62% in 2023 in bloodstream) and third-generation cephalosporins (50% to 74% in bloodstream) were found to be increasing, with the emergence of ceftazidime–avibactam resistance. Third-generation cephalosporin resistance in Escherichia coli increased initially, but subsequently stabilized, while carbapenem resistance rates and carbapenem-resistant E. coli isolation rates remained low and stable. Pseudomonas aeruginosa showed increasing resistance trends with year-to-year fluctuations.
Conclusion: The resistance exhibited divergent trends: E. faecium, S. aureus, K. pneumoniae, E. coli, P. aeruginosa had rising resistance rates and resistant bacteria isolation rate, while E. faecalis, A. baumannii, were relatively stable. Resistance rates serve as an indicator for updating local empiric therapy guidelines. Isolation rates represent a primary outcome measure for effectiveness of infection prevention and control programs.
Keywords: Enterococcus faecalis, E. faecium, Staphylococcus aureus, Acinetobacter baumannii, Klebsiella pneumoniae, Escherichia coli, Pseudomonas aeruginosa, antibacterial resistance rate, multi-drug resistance, carbapenem resistance, vancomycin resistance, Extended spectrum beta-lactamase, ESBL, Türkiye